Signor Alfeo, in bibliografia è riportata - tra le varie cose - una REVISIONE di studi clinici e non un semplice studio. Ecco l'articolo intero: ➡️https://t.co/b6NSjLkALm Se non dovesse bastarle, qui c'è anche il rapporto dell'EMA: ➡️https://t.co/TEfuR
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
RT @doctorveronica: 18 will never happen in real life :) https://t.co/xoWfilWtOr
Let's point out that you've CHERRY-PICKED: the 8-18% is ABOVE existing protection: "The 9vHPV vaccine induced a very robust immune response against all vaccine types, with seroconversion rates close to 100%". Can you not interpret, or did you intentiona
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
18 will never happen in real life :) https://t.co/xoWfilWtOr
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
RT @lifebiomedguru: What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prev…
Expose true number of teen girls & boys injured and dying from Gardasil vaccines https://t.co/fQTh4OmT2R
What % of HPV-related cancers might be prevented by Gardasil 9? "The additional coverage offered by the 9vHPV may prevent a significant proportion of HPV-related cancers (variable between 8% and 18%)" https://t.co/nPX7KbHEdn Let's use 18%.
@1002Loola @Gflannelly2014 @climurphy https://t.co/9cRp12JWbG measures HPV types in cervical cancer. https://t.co/iLqv8M6X9h shows how well 9valent vaccine prevents them.
Spotlight on the 9-valent HPV vaccine https://t.co/6rWoRowBCy
@Bess_Stillman @DrJenGunter See also https://t.co/iLqv8M6X9h "revaccination... should not be considered a good policy option". But for a high risk individual, maybe.
@itsmepanda1 https://t.co/iLqv8M6X9h summarizes studies of nonavalent vaccine, but I didn't see an all-types CIN3 efficacy measurement.
RT @DovePress: Spotlight on the 9-valent HPV vaccine https://t.co/msWFwbA8E9 https://t.co/y1krlcDbFT
Spotlight on the 9-valent HPV vaccine https://t.co/msWFwbA8E9 https://t.co/y1krlcDbFT
RT @doritmi: Spotlight on the 9-valent HPV vaccine | DDDT @DovePress #vaccines #vaxwithme #vaccineswork https://t.co/wmTeMTKuzd
Spotlight on the 9-valent HPV vaccine | DDDT @DovePress #vaccines #vaxwithme #vaccineswork https://t.co/wmTeMTKuzd